This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: No defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ConditionDefinition.
Generated Narrative: ConditionDefinition
Resource ConditionDefinition "example"
url: http://hl7.org/fhir/ConditionDefinition/example
identifier: id: urn:oid:2.16.840.1.113883.4.642.25.1
name: Hyperlipidemia
title: Hyperlipidemia Status
status: draft
date: 2019-05-26T10:44:00+10:00
description: Hyperlipidemia Status
code: Hyperlipidemia (disorder) (SNOMED CT#55822004)
hasSeverity: false
hasBodySite: false
hasStage: false
definition: https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf
observation
code: Lipid Panel (LOINC#24331-1 "Lipid 1996 panel - Serum or Plasma")
observation
code: Cholesterol (LOINC#35200-5 "Cholesterol [Moles/volume] in Serum or Plasma")
observation
code: Triglyceride (LOINC#35217-9 "Triglyceride [Moles/volume] in Serum or Plasma")
observation
code: Cholesterol in HDL (LOINC#2085-9 "HDL Cholesterol")
observation
code: LDL Chol. (Calc) (LOINC#13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")
- | Code |
* | Gemfibrozil (RxNorm#203151) |
- | Reference |
* | http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6 |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.